Growth Metrics

Nova (NVMI) Cash & Equivalents (2016 - 2025)

Nova filings provide 17 years of Cash & Equivalents readings, the most recent being $214.5 million for Q4 2025.

  • On a quarterly basis, Cash & Equivalents rose 35.93% to $214.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $214.5 million, a 35.93% increase, with the full-year FY2025 number at $214.5 million, up 35.93% from a year prior.
  • Cash & Equivalents hit $214.5 million in Q4 2025 for Nova, down from $521.6 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $521.6 million in Q3 2025 to a low of $96.1 million in Q1 2023.
  • Median Cash & Equivalents over the past 5 years was $147.5 million (2024), compared with a mean of $172.8 million.
  • Biggest five-year swings in Cash & Equivalents: surged 797.45% in 2021 and later tumbled 51.91% in 2022.
  • Nova's Cash & Equivalents stood at $232.3 million in 2021, then crashed by 51.91% to $111.7 million in 2022, then dropped by 3.71% to $107.6 million in 2023, then soared by 46.67% to $157.8 million in 2024, then surged by 35.93% to $214.5 million in 2025.
  • The last three reported values for Cash & Equivalents were $214.5 million (Q4 2025), $521.6 million (Q3 2025), and $157.8 million (Q2 2025) per Business Quant data.